https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Thus far in 2025, notable developments in retinal disease have included several newsworthy associations with the widely used GLP-1 agonist drugs for diabetes and weight loss, a study of patient satisfaction with treatment for…
